We are live on ! Find out more
KMTS

Kestra Medical Technologies

107 hedge funds and large institutions have $1.49B invested in Kestra Medical Technologies in 2025 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 51 increasing their positions, 11 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 6

364% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 11

34% more funds holding

Funds holding: 80107 (+27)

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

30% more capital invested

Capital invested by funds: $1.15B → $1.49B (+$339M)

2.17% more ownership

Funds ownership: 94.07%96.23% (+2.2%)

Holders
107
Holders Change
+27
Holders Change %
+33.75%
% of All Funds
1.3%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
33
Increased
51
Reduced
11
Closed
6
Calls
Puts
Net Calls
Net Calls Change

KMTS Hedge Fund Activity: Q4 2025 in Review

107 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Kestra Medical Technologies (KMTS) for Q4 2025, worth a combined $1.49B — up 30% from $1.15B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new KMTS positions and 6 closed out — a net gain of 27 holders — while 51 added to existing stakes and 11 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $65.2M. The largest seller was Bain Capital Investors, cutting an estimated $47.6M.

  • 107 institutional investors held Kestra Medical Technologies (KMTS) as of Q4 2025, up from 80 in Q3 2025.
  • Funds reported $1.49B of Kestra Medical Technologies stock for Q4 2025, up 30% quarter-over-quarter.
  • 33 funds opened new Kestra Medical Technologies positions in Q4 2025 and 6 closed out, a net change of +27 holders.
  • The largest Kestra Medical Technologies buyer in Q4 2025 was T. Rowe Price Associates, an estimated $65.2M added.
  • The largest Kestra Medical Technologies seller in Q4 2025 was Bain Capital Investors, an estimated $47.6M sold.

Based on aggregated 13F filings for Q4 2025.